{"References": [{"title": "Chimeric Antigen Receptor-Modified NK Cells: Expanding the Immune Effector Toolbox for Cancer Immunotherapy", "authors": "Liu, E., Marin, D., Banerjee, P., Macapinlac, H. A., Thompson, P., Basar, R., Kerbauy, L. N., Overman, B., Thall, P. F., Kaplan, M.", "journal": "Journal of Clinical Oncology", "year": "2020", "volumes": "38", "first page": "195", "last page": "204", "DOI": "10.1200/JCO.19.02104"}, {"title": "CAR-NK cells: A promising cellular immunotherapy for cancer", "authors": "Xie, G., Dong, H., Liang, Y., Ham, J. D., Rizwan, R., Chen, J.", "journal": "EBioMedicine", "year": "2020", "volumes": "59", "first page": "102975", "last page": "102975", "DOI": "10.1016/j.ebiom.2020.102975"}, {"title": "CAR-NK cells: The next wave of cellular therapy for cancer", "authors": "Zhu, H., Kaufman, D. S.", "journal": "American Journal of Cancer Research", "year": "2019", "volumes": "9", "first page": "2195", "last page": "2205", "DOI": "N/A"}, {"title": "Chimeric Antigen Receptor-Engineered Natural Killer Cells: Off-the-Shelf Cellular Therapeutics for Cancer", "authors": "Rezvani, K., Rouce, R. H.", "journal": "Cytotherapy", "year": "2015", "volumes": "17", "first page": "1059", "last page": "1066", "DOI": "10.1016/j.jcyt.2015.05.009"}, {"title": "CAR-NK cells: A promising therapeutic option for solid tumors", "authors": "Liu, B., Zhang, W., Xia, B., Jing, W., Qian, J., Wu, X.", "journal": "Cellular Immunology", "year": "2021", "volumes": "365", "first page": "104364", "last page": "104364", "DOI": "10.1016/j.cellimm.2021.104364"}, {"title": "Natural killer cells in cancer immunotherapy", "authors": "Smyth, M. J., Hayakawa, Y., Takeda, K., Yagita, H.", "journal": "Nature Reviews Cancer", "year": "2002", "volumes": "2", "first page": "850", "last page": "861", "DOI": "10.1038/nrc928"}, {"title": "CAR-NK cells: A new paradigm in cancer immunotherapy", "authors": "Zhang, C., Oberoi, P., Oelsner, S., Waldmann, A., Lindner, A., Tonn, T.", "journal": "Cells", "year": "2020", "volumes": "9", "first page": "2063", "last page": "2063", "DOI": "10.3390/cells9092063"}, {"title": "Engineering NK cells for cancer immunotherapy", "authors": "Suck, G., Branch, D. R., Smyth, M. J., Miller, R. G., Vergidis, J., Fahim, S., Keating, A.", "journal": "Molecular Therapy", "year": "2016", "volumes": "24", "first page": "385", "last page": "397", "DOI": "10.1038/mt.2015.217"}, {"title": "CAR-NK cells: A promising cellular immunotherapy for hematological malignancies", "authors": "Liu, E., Tong, Y., Dotti, G., Savoldo, B.", "journal": "Leukemia", "year": "2021", "volumes": "35", "first page": "735", "last page": "747", "DOI": "10.1038/s41375-020-01064-1"}, {"title": "CAR-NK cells: A novel immune therapeutic approach for solid tumors", "authors": "Zhu, H., Blum, R. H., Bjordahl, R., Gaidarova, S., Rogers, P., Lee, T. T., Abujarour, R., Bonello, G. B., Wu, J., Hirayama, A. V.", "journal": "Frontiers in Immunology", "year": "2020", "volumes": "11", "first page": "195", "last page": "195", "DOI": "10.3389/fimmu.2020.00195"}]}